As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of RiverNorth/DoubleLine Strategic Opp Fund. The largest reported stake is Morgan Stanley's, at 10.2%. 11 filings are on record since August 6, 2025 (Schedule 13G/A, October 13, 2026).
Sell to companies like RiverNorth/DoubleLine Strategic Opp Fund? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Wells Fargo & Company · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 1,887,415 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-29
- · Reporting person: Morgan Stanley · Sole voting: 0 · Shared voting: 1 · Sole dispositive: 0 · Shared dispositive: 245,955 · SCHEDULE 13G/A, 2026-10-13
- · Holder: Wells Fargo & Company · Percent: 6.6% · SCHEDULE 13G/A
- · Holder: Wells Fargo & Company · Percent: 6% · SCHEDULE 13G/A
- · Holder: Morgan Stanley · Percent: 15.5% · SCHEDULE 13G/A
RiverNorth/DoubleLine Strategic Opp Fund has 11 Schedule 13D or 13G filings on record since 2025-08-06. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 10.2% | 245,955 | SCHEDULE 13G/A, 2026-10-13 | 2026-08-31 | |
| Wells Fargo & Company | 7.6% | 1,887,415 | SCHEDULE 13G/A, 2026-10-29 | 2026-09-30 |
Holding shares or following this stake? See who's behind RiverNorth/DoubleLine Strategic Opp Fund and the warning signs.
Free to see. No signup.
Keep reading
More on RiverNorth/DoubleLine Strategic Opp Fund and the records around it.
RiverNorth/DoubleLine Strategic Opp Fund elsewhere on the record
Companies that share a holder
- Wells Fargo & Company also filed stake reports on 16 other companies: Ares Dynamic Credit Allocation Fund (Oct 2026), BlackRock MuniYield PA Quality (Oct 2026), Ellsworth Growth and Income (Oct 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), Arbutus Biopharma Corp (Oct 2026), Evolent Health, Inc. (Sep 2026)
Watch RiverNorth/DoubleLine Strategic Opp Fund
Get an email when RiverNorth/DoubleLine Strategic Opp Fund files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on RiverNorth/DoubleLine Strategic Opp Fund?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on RiverNorth/DoubleLine Strategic Opp Fund: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RiverNorth/DoubleLine Strategic Opp Fund covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Morgan Stanley | 0 | 1 | 0 | 245,955 | SCHEDULE 13G/A, 2026-10-13 |
| Morgan Stanley Smith Barney LLC | 0 | 1 | 0 | 245,955 | SCHEDULE 13G/A, 2026-10-13 |
| Wells Fargo & Company | 0 | 0 | 1,887,415 | 0 | SCHEDULE 13G/A, 2026-10-29 |
The latest filing identifies RiverNorth/DoubleLine Strategic Opp Fund by CUSIP 76882G107 and gives its principal executive office as 360 S. ROSEMARY AVE, SUITE 1420, WEST PALM BEACH, FL 33401 (SCHEDULE 13G/A, 2026-10-29).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-06 | Morgan Stanley | 14.8% | SCHEDULE 13G/A |
| 2025-11-07 | Morgan Stanley | 5.9% | SCHEDULE 13G/A |
| 2025-11-07 | Morgan Stanley | 11.9% | SCHEDULE 13G/A |
| 2026-01-29 | Wells Fargo & Company | 5.3% | SCHEDULE 13G |
| 2026-02-12 | Morgan Stanley | 14.4% | SCHEDULE 13G/A |
| 2026-05-12 | Wells Fargo & Company | 6% | SCHEDULE 13G/A |
| 2026-05-12 | Morgan Stanley | 15.5% | SCHEDULE 13G/A |
| 2026-05-12 | Morgan Stanley | 7.5% | SCHEDULE 13G/A |
| 2026-07-28 | Wells Fargo & Company | 6.6% | SCHEDULE 13G/A |
| 2026-10-13 | Morgan Stanley | 10.2% | SCHEDULE 13G/A |
| 2026-10-29 | Wells Fargo & Company | 7.6% | SCHEDULE 13G/A |
Questions about who owns RiverNorth/DoubleLine Strategic Opp Fund
Who owns RiverNorth/DoubleLine Strategic Opp Fund?
On this page, 2 holders' latest ownership filings report 5% or more of RiverNorth/DoubleLine Strategic Opp Fund: Morgan Stanley (10.2%, Schedule 13G/A, filed 2026-10-13) and Wells Fargo & Company (7.6%, Schedule 13G/A, filed 2026-10-29).
Who are the largest shareholders of RiverNorth/DoubleLine Strategic Opp Fund?
By the share each holder's latest filing reports, the largest holders of RiverNorth/DoubleLine Strategic Opp Fund on this page are Morgan Stanley (10.2%) and Wells Fargo & Company (7.6%).
When did Morgan Stanley buy into RiverNorth/DoubleLine Strategic Opp Fund?
The filings give report dates, not purchase dates. The earliest filing from Morgan Stanley on this page is the Schedule 13G/A, filed 2025-08-06, reporting 14.8%; its latest, Schedule 13G/A filed 2026-10-13, reports 10.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for RiverNorth/DoubleLine Strategic Opp Fund. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.